Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: Preliminary results of an ongoing study

CardioVascular and Interventional Radiology

Volumn 21, Issue 5, 1998, Pages 375-379

  Strecker, Ernst Peter K ^a   Göttmann, Dieter ^a   Boos, Irene B L ^a   Vetter, Sylvia ^a  

^a Department of Radiology   (Germany)

Author keywords

Arteries, extremities; Grafts and prostheses; Hepatin; Stenosis or obstruction; Transluminal angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; FEMORAL ARTERY; HUMAN; INTERVENTIONAL RADIOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; RESTENOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL VEIN; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; POPLITEAL VEIN; POSTOPERATIVE PERIOD; PREMEDICATION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECURRENCE; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0031658270     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002709900283     Document Type: Article

References (28)

1. Herr D, Lenke D, Müller C-D, Betz E, Hämmerle H (1989) Final report of the research project 0318854. A sponsored report by the Federal Secretary for Research and Technology. (in German) Bonn. Germany
2. Betz E, Schlote W (1979) Responses of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 74:10-20
3. Hanke H, Oberhoff M, Hanke S, Hassenstein S, Kamenz J, Schmid KM, Betz E, Karsch KR (1992) Inhibition of cellular proliferation after experimental balloon angioplasty by low-molecular weight heparin Circulation 85:1548-1556
4. Karsch KR, Preisack MB, Baildon R, Eschenfelder V, Foley D, Garcia EJ, Kaltenbach M, Meisner C, Selbmann HK, Serruys PW, Shiu MF, Sujatta M, Bonan R (1996) Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty: Results of a randomized, double-blind, unfractionated heparin and placebo-controlled multicenter trial (REDUCE Trial). J Am Coll Cardiol 28:1437-1443
5. Rutherford RB, Becker GJ (1991) Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral artery disease. J Vasc Interv Radiol 2:169-174
6. Henry M, Amor M, Ethevenot G, Henry I, Amicabile C, Beron R, Mentre B, Allaoui M, Touchot M (1995) Palmaz stent placement in iliac and femoropopliteal arteries: Primary and secondary patency in 310 patients with 2-4-year follow-up. Radiology 196:167-174
7. Chatelard P, Guibourt C (1996) Long-term results with a Palmaz stent in the femoropopliteal arteries. J Cardiovasc Surg Torino 37 [Suppl 1]:67-72
8. Martin EC, Katzen BT, Benenati JF, Diethrich EB, Dorros G, Graor RA, Horton KM, Iannone LA, Isner JM, Ramee SR, et al. (1995) Multicenter trial of the Wallstent in the iliac and femoral arteries. J Vasc Interv Radiol 6:843-849
9. Strecker EP, Boos IBL, Göttmann D (1997) Femoropopliteal artery stent placement: Evaluation of long-term success. Radiology 205:375-383
10. Haudenschild CC (1995) Pathophysiology of reocclusion and restenosis. Fibnnolysis 9 [Suppl 1]:44-47
11. Ross R (1986) The pathogenesis of atherosclerosis - an update. N Engl J Med 314:488-497
12. Kamenz J, Hanke H, Hassenstein S, Oberhoff M, Xie DY, Betz E, Karsch KR (1992) Intimale Reaktion und Inzidenz thrombotischer Verschlüsse nach Stentimplantation im Vergleich zur Ballondilatation am Kaninchen. (abstract) Meeting of the DGAF, April 4-7, 1992, Blaubeuren, Germany
13. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR (1990) Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 67:651-659
14. Clowes AW, Karnowsky MJ (1977) Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265:625-626
15. Hämmerle H, Betz E, Herr D (1991) Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins. Vasa 20:207-215
16. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB 3d (1989) Effect of 18 to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 117:777-782
17. Currier JW, Pow TK, Haudenschild CC, Minihan AC, Faxon DP (1991) Low molecular weight heparin (enoxaparin) reduced restenosis after iliac angioplasty in the hypercholesterolemic rabbit. J Am Coll Cardiol 17:118B-125B
18. Reilly CG, Fritze LMS, Rosenberg RD (1986) Heparin inhibition of smooth muscle cell proliferation: A cellular site of action. J Cell Physiol 129:11-19
19. Schmidt T, Tebbe U, Schrader J, Brune S, Kreuzer H (1990) Pharmacological therapy after coronary angioplasty. Klin Wochenschr 68:294-295
20. Faxon D, Spiro T, Minor S, Douglas J, Cote G, Dorosti K, Gottlieb R, Califf R, Topol E, Gordon J (1992) Enoxaparin, a low molecular weight heparin, in the prevention of restenosis after angioplasty: Results of a double-blind randomized trial. J Am Coll Cardiol 19:258B
21. Roth D, Betz E (1992) Kultivierte Gefäβwandzellen des Menschen. Ein Modell zur Aufklärung potentiell antiarteriosklerotisch wirkender Substanzen. Vasa 35 [Suppl]:125-127
22. Schmid KM, Preisack M, Völker W, Sujatta M, Karsch KR (1993) First clinical experience with low molecular weight heparin LU47311 (reviparin) for prevention of restenosis after percutaneous transluminal coronary angioplasty. Semin Thromb Hemost 19:155-159
23. Richter GM, Simon C, Dahlke A, Lammer J, Nicholas V, Liermann D, Tesdal K, Huppert P, Rabbia C (1997) Long-term results of the Randomized European Trial Femoral Stent versus Angioplasty (REFSA) Study. (abstract) Cardiovasc Intervent Radiol 20 [Suppl 1]:S73
24. Sapoval MR, Long AL, Raynaud AC, Beyssen BM, Fiessinger JN, Gaux JC (1992) Femoropopliteal stent placement: Long-term results Radiology 184:833-839
25. Henry M, Amor M, Beyar R, Henry I, Porte JM, Mentre B, Tricoche O, Ethevenot G (1996) Clinical experience with a new nitinol self-expanding stent in peripheral arteries. J Endovasc Surg 3:369-379
26. Starck E, Knaupp D, Dukiet D, Boderke S, Truss J (1996) Memotherm and tantalum stents in femoropopliteal arteries. (abstract) Fifth International and Interdisciplinary Symposium on Endoluminal Stents and Grafts, October 10-13, Georgetown University Medical Center, Washington, DC. Cardiovasc Intervent Radiol 20:70
27. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB (1996) Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation 94: 35-43
28. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM (1995) Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91:1676-1688